The 3 Small CRISPR Biotechs That Could Cure 10,000 Diseases Post author:Sam Post published:February 4, 2018 Post category:BioPharma A look at three small biotech companies that appear to be leading the CRISPR race. Source: BioSpace You Might Also Like FDA Slaps Clinical Hold on Concert Pharma's Hair Loss Drug May 16, 2017 DaVita Clinical Research Launches Alliance Site Network For Early Stage CKD Trials June 14, 2017 Japanese Regulators Approve s For Lung Cancer Drug February 2, 2017
